New drug duo tested in fight against tough breast cancer
NCT ID NCT04986852
First seen Jan 09, 2026 · Last updated Apr 08, 2026 · Updated 9 times
Summary
This study tested whether combining two drugs, olinvacimab and pembrolizumab, could help control advanced triple-negative breast cancer that had spread. It was for women whose cancer had worsened after at least one prior treatment. The trial was stopped early and did not complete its planned enrollment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC TRIPLE-NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hollywood Private Hospital
Nedlands, Western Australia, 6009, Australia
Conditions
Explore the condition pages connected to this study.